Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AdvisorShares Pure US Cannabis ETF (MSOS)

NYSEArca - NYSEArca Delayed Price. Currency in USD
Add to watchlist
10.34-0.01 (-0.10%)
At close: 04:00PM EDT
10.34 0.00 (0.00%)
After hours: 07:55PM EDT
Advertisement
Sign in to post a message.
  • M
    Maverick
    The 10th Amendment says that the Federal government only has the power given to it by the Constitution.

    “The powers not delegated to the United States by the Constitution, nor prohibited by it to the States, are reserved to the States respectively, or to the people.”
    So in order to make drugs illegal that power must be found somewhere in the Constitution. Otherwise, the Federal government does not have the power to interfere in that aspect of life.

    Well there ya go.
  • P
    Pro-MJ
    Anybody on this thread think we will see US $10.81 again??...missed that price point last week.
  • T
    Tom
    $CRLBF conversation
    Terrific article on where things are heading politically by Natalie Fertig in Politico! If you're not buying now, you don't belong in these $CRLBF $GTBIF $VRNOF $CURLF $TCNNF $TRSSF $MSOS. The share prices have been unabashedly hammered and present incredible value. My 1st half bonus is solid and I just hope they don't start crushing shorts just yet. Soon, but not yet.
    Bullish
  • P
    Pro-MJ
    With Recession chatter getting louder and louder, looks like more blood(selling) is coming...now I'm wondering if the US $9's/$8's is possible??
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF
    The Etf MSOS had no changes to the top ten positions this past week.
    The AUM dropped to $583.9 millions.
    TCNNF is #1 at 17.41%,, CURLF 14.74%, VRNOF 13.76%, GTBIF 13.38%,
    CURLF 7.30%, TRSSF 5.05%, CCHWF 3.92%, AYRWF 3.69% and JUSHF 2.66%. The top 10 make up 82.01% of the AUM.
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF This week’s commentary by Alan Brochstein
    Friends,
    Alan Brochstein here! Cannabis stocks finally rallied this week slightly. Since we shared our sector bullishness in this newsletter a few weeks ago, the Global Cannabis Stock Index has actually dropped a lot. The index is up nearly 4% from the multi-year closing low set during this week, and, at 16.34, it is down about 15% in June and has fallen by over 50% in 2022. With little chance of recovering the June loss in the next four days, it appears that this will be the 18th consecutive monthly decline. We will soon detail the performance for the month of all seven of our indexes.

    This weekend in a video for subscribers at 420 Investor, I described how a lot of the stocks I follow are testing or have taken out the lows from March of 2020. Since then, the S&P 500 is up about 77%. Simply put, the cannabis sector has been absolutely hammered. We have shared in the past our reasons for being bullish: the expansion of many state markets into adult-use, the addition of new dispensaries in Illinois and very low valuations in our view.

    We always try to understand the sentiment in the cannabis sector. Right now, sentiment is generally negative, which encourages us as contrarians. When we look at the stocks and the sub-sectors, we see a very oversold market. The Global Cannabis Stock Index made a new 52-week closing low this week at 15.76 on Wednesday. For perspective, we think it's important to remember that the closing low in March 2020 was slightly higher than our close Friday (16.42 then, 16.32 now). It's a near double-bottom!

    The American Cannabis Operators Index is down a bit less than the overall market, having declined by nearly 47% in 2022, while the Ancillary Cannabis Index has fallen by more (53.8%). While the overall Canadian market has declined about the same as the overall market, the largest ones have been sold aggressively. Canadian Cannabis LP Tier 1 Index, which consists of five companies doing more than $30 million in quarterly revenue, has declined more than 56% and trades well below the 2020 low now. Aurora Cannabis, Canopy Growth, HEXO Corp. and Organigram have made recent lows below the 2020 lows, while Tilray still holds above its 2020 low.

    When looking at the prices, there are two factors that we like to assess: oversold and overextended. The way we measure oversold is by comparing to the 150-day moving average, and the 29 stocks on the 420 Investor Focus List are anywhere from 13% to 76% below that level currently. The average is 43% below. This is quite oversold in our view. When looking at a chart, we define a trend as overextended when the 10-dma has been below the 50-dma and the 50-dma below the 150-dma for more than 13 weeks. The stocks are for the most part overextended to the downside, with several names reaching that point in mid-July.

    Cannabis stocks being oversold and overextended to the downside sets us up for at least a bounce if the rally we expect doesn't materialize. Cannabis stocks are very out of favor now, and we continue to believe that this is a good time for investors to increase their exposure.
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF. Industry commentary from NCV…
    Friends,
    Two weeks ago, we suggested that the Global Cannabis Stock Index, then down 43% in 2022, was likely to bottom before year-end. It has fallen further (by 15.4% subsequently) and is now about 52% lower this year. The bullish factors we cited then are still intact, and we are more interested than two weeks ago at these lower prices. Despite that, we are clearly in a bear market for stocks generally, and our optimism doesn't help in choosing the best time to enter or to expand positions in the cannabis sector. The future looks very bright in contrast to the price action lately, and we want to discuss how investors should be prepared for changes ahead.

    We are expecting big market growth in several states. Illinois is currently increasing its dispensary count by more than 100%. Two weeks ago, we mentioned Eastern states generally. Today, we want to refine that observation and mention New York and New Jersey, both transitioning to adult-use, at the top of the list. Virginia can also be included, and there are some other states like Maryland, Ohio and Pennsylvania that may move to legalize adult-use as well. The big takeaway is that investors need to be ready for strong top-line growth.

    Beyond that, there are other factors investors should understand. First, capital-raising could get challenging. New operations typically consume cash, and not all cannabis companies are in a strong position at this time. Investors need to be in a position to avoid capital raises, as they can now depress the equity price of the issuer substantially.

    A final area that investors should consider is market positioning. There are some multi-state operators that are in many states already and their ability to expand into new states at this time is in question in our view. Simultaneously, there are MSOs that have a more concentrated market presence. The smaller MSOs come to mind, such as Ascend Wellness, Jushi and TerrAscend as well as Planet 13 Holdings. Each of them has new markets coming on now but is also in a position to expand to new markets. The California operators have expansion opportunities as well.

    We remain uncertain about the timing of improved prices for cannabis companies, but, as we said two weeks ago: the current valuations seem too low. We expect prices to rise as the fundamentals stabilize and improve in the future
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF
    The AUM dropped further to $570.3 millions. The Etf MSOS had several changes to the top ten positions this past week. Position changes:
    GTBIF. +50k
    VRNOF +100k
    TRSSF +100k
    GRWG - 5k
  • D
    Duc
    Climb act should benefit us canabis companies but they are in otc market. It is still red anyway
  • J
    Jeff1975
    looking to start a big position in MsOs is there any chance this etf could dissolve?
    Neutral
  • M
    Maverick
    Grandfather Mitch is watching and he’s very disappointed you are partaking in the hemp smokes.
  • B
    Brandon
    I quit shorting awhile ago. I made a pile of money off this one on the way down. Looks like I could have kept going, but I didn't want to risk it.

    Amazing to see there are STILL people here buying all the garbage coming from Marijuana Moment and Todd Harrison. You would think after being burned by them around a dozen times people would finally capitulate and tell them to F off.

    Apparently some of you are really stubborn. LOL
  • D
    Dan
    Full disclosure, I just bought a lot of GNLN but I do want to say.. this safe banking plus bill looks promising.. personally, I do believe I will now begin to pressure lawmakers to abide by their voting % on an issue.. obviously they have leeway at 55-45 or even 60-40 issues but on 70-30 issues with only an older generation In that 30.. I think it could begin to turn to cosmos interference into congress under Thomas Jefferson law. It could get real real quick.. but i expect legislation before the Supreme Court says this group is idiots
  • T
    Three blind mice
    Definatly building a strong base here. If it holds the down trend could be over. There is also tremendous pressure to pass SAFE BANKING, so lets see what happens????
    Bullish
  • M
    Max
    I might be interested again at $7.
  • J
    Jt
    $GTBIF conversation
    Marijuana moment.. a few minutes ago.. could be HUGE.
    $GTBIF $TCNNF $CRLBF $CURLF$ $ACB $MSOS
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF
    The AUM dropped further to $517.5 millions. The Etf MSOS had several changes to the top ten positions this past week. Position changes:
    GTBIF +300k, CURLF +100k, GRWG -14k. The top 10 still account for 82.5% of the portfolio.
  • P
    Pro-MJ
    We are in uncharted waters, no historical "candles" to determine buy/sell decisions...markets look horrible so I'm going to wait to add/buy more...secretly hoping for the US $9.50 - $10.50 range.
  • j
    jj
    $VRNOF conversation
    $MSOS, $AYRWF, $CCHWF, $CRLBF, $CURLF, $GTBIF, $JUSHF, $GRWG, $TCNNF, $TRSSF, $VRNOF This week’s commentary by Alan Brochstein
    focused on Canopy Growth. For the full story see NCV which will contain the commentary later today. $CGC
  • P
    Pro-MJ
    Got my last bullet/bid for this one at US $10.19...bottom feeding is getting tougher and tougher for this sector.
Advertisement
Advertisement